These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21075978)

  • 21. Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosis.
    Nuermberger E; Tyagi S; Tasneen R; Williams KN; Almeida D; Rosenthal I; Grosset JH
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1522-4. PubMed ID: 18285479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of the effect of morphazinamide and pyrazinamide in the treatment of chronic tuberculosis].
    Zierski M
    Gruzlica; 1965 Sep; 33(9):769-71. PubMed ID: 5859903
    [No Abstract]   [Full Text] [Related]  

  • 23. [Kidney function in patients with pulmonary tuberculosis during treatment with antitubercular agents, with special reference to pyrazinamide].
    Spychalski W; Grzegorzewska A; Westfal I
    Pneumonol Pol; 1987 Oct; 55(10):454-7. PubMed ID: 3438179
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
    Ahmad Z; Nuermberger EL; Tasneen R; Pinn ML; Williams KN; Peloquin CA; Grosset JH; Karakousis PC
    J Antimicrob Chemother; 2010 Apr; 65(4):729-34. PubMed ID: 20123722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The antitubercular activity of a pyrazinamide derivative: morphazinamide].
    Grassi C
    Acta Tuberc Pneumol Belg; 1966; 57(3):196-210. PubMed ID: 4862621
    [No Abstract]   [Full Text] [Related]  

  • 26. Short-course chemotherapy for pulmonary tuberculosis.
    Fox W; Mitchison DA
    Am Rev Respir Dis; 1975 Jun; 111(6):845-8 CONTD. PubMed ID: 49163
    [No Abstract]   [Full Text] [Related]  

  • 27. Pyrazinamide deamidase activity in tuberculous disease.
    Gurumurthy P; Krishnamurthy PV; Garhupati Sarma G
    Am Rev Respir Dis; 1981 Jul; 124(1):97. PubMed ID: 7020509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
    Dawson R; Diacon AH; Everitt D; van Niekerk C; Donald PR; Burger DA; Schall R; Spigelman M; Conradie A; Eisenach K; Venter A; Ive P; Page-Shipp L; Variava E; Reither K; Ntinginya NE; Pym A; von Groote-Bidlingmaier F; Mendel CM
    Lancet; 2015 May; 385(9979):1738-1747. PubMed ID: 25795076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-dependent activity of pyrazinamide in animal models of intracellular and extracellular tuberculosis infections.
    Ahmad Z; Fraig MM; Bisson GP; Nuermberger EL; Grosset JH; Karakousis PC
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1527-32. PubMed ID: 21282447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid biochemistry takes a stand against tuberculosis.
    Draper P
    Nat Med; 2000 Sep; 6(9):977-8. PubMed ID: 10973314
    [No Abstract]   [Full Text] [Related]  

  • 32. Pyrazinamide.
    Tuberculosis (Edinb); 2008 Mar; 88(2):141-4. PubMed ID: 18486055
    [No Abstract]   [Full Text] [Related]  

  • 33. Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.
    Lanoix JP; Betoudji F; Nuermberger E
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1091-6. PubMed ID: 26643352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The present state of short course chemotherapy including pyrazinamide in Japan].
    Yamagishi F
    Nihon Kokyuki Gakkai Zasshi; 2004 Jun; 42(6):481-5. PubMed ID: 15228133
    [No Abstract]   [Full Text] [Related]  

  • 35. A case of skin and lung tuberculosis: diagnostic difficulties.
    Colasanti P; Cardone M; Zanchini R; Cordedda M; Grande A; Mozzillo R
    G Ital Dermatol Venereol; 2013 Oct; 148(5):538-40. PubMed ID: 24005149
    [No Abstract]   [Full Text] [Related]  

  • 36. Modern short-course regimens in the treatment of tuberculosis.
    Fox W
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):122-32. PubMed ID: 2999948
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative results of the therapeutic action of morphazinamide and pyrazinamide combined with ethionamide in experimental tuberculosis in guinea pigs].
    Rözewska M
    G Ital Chemioter; 1967; 14(1):49-57. PubMed ID: 5622725
    [No Abstract]   [Full Text] [Related]  

  • 38. [Acute respiratory distress syndrome: a manifestation of immune reconstitution in an HIV-negative patient with tuberculosis].
    Wikman PE; Jover F; Peris J; Cuadrado JM
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):132-3. PubMed ID: 19254644
    [No Abstract]   [Full Text] [Related]  

  • 39. [Short-term treatment of pulmonary tuberculosis].
    Karuga WK
    Bull Int Union Tuberc; 1974; 49(1):388-97. PubMed ID: 4143178
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative study of the treatment of pulmonary tuberculosis with isoprodian and pyrazinamide as well as isoprodian and rifampicin].
    Sighart H; Opl G; Weirich H
    Wien Med Wochenschr; 1982 Nov; 132(22):559-61. PubMed ID: 7168180
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.